Silexion Therapeutics Corp (SLXN) stock
SLXNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SLXNW
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.15+0.00 (0.00%)
Close on Oct 19, 2026Market cap $28.29KP/E 0.0Yield –
Silexion Therapeutics cash
Cash and short-term investments held at the end of each period.
Silexion Therapeutics's cash was $4.76M at Sep 30, 2026. For fiscal 2025 it was $5.99M, up 371.7% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.99M | +371.7% |
| FY2024 | Dec 31, 2024 | $1.27M | -72.7% |
| FY2023 | Dec 31, 2023 | $4.65M | -44.1% |
| FY2022 | Dec 31, 2022 | $8.31M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $4.76M | -48.9% |
| Q2 FY2026 | Jun 30, 2026 | $2.32M | -34.5% |
| Q1 FY2026 | Mar 31, 2026 | $2.50M | -59.9% |
| Q4 FY2025 | Dec 31, 2025 | $5.99M | +371.7% |
| Q3 FY2025 | Sep 30, 2025 | $9.32M | +360.9% |
| Q2 FY2025 | Jun 30, 2025 | $3.54M | +102.9% |
| Q1 FY2025 | Mar 31, 2025 | $6.23M | +120.2% |
| Q4 FY2024 | Dec 31, 2024 | $1.27M | -72.7% |
| Q3 FY2024 | Sep 30, 2024 | $2.02M | -65.2% |
| Q2 FY2024 | Jun 30, 2024 | $1.75M | -73.1% |
| Q1 FY2024 | Mar 31, 2024 | $2.83M | -64.3% |
| Q4 FY2023 | Dec 31, 2023 | $4.65M | -44.1% |
| Q3 FY2023 | Sep 30, 2023 | $5.81M | – |
| Q2 FY2023 | Jun 30, 2023 | $6.49M | – |
| Q1 FY2023 | Mar 31, 2023 | $7.92M | – |
| Q4 FY2022 | Dec 31, 2022 | $8.31M | – |
See a number that looks wrong?